Results 291 to 300 of about 24,787 (310)

Dupilumab

Reactions Weekly, 2019
  +6 more sources

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2022
Michael J Cork, Andreas Wollenberg, Mercedes E. Gonzalez   +2 more
exaly  

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

Lancet, The, 2022
Kilian Eyerich, Fernando Valenzuela
exaly  

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

New England Journal of Medicine, 2022
Evan Dellon, Ikuo Hirano, Mirna Chehade
exaly  

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

New England Journal of Medicine, 2021
Leonard Benjamin Bacharier, Jorge F Maspero, Alessandro Fiocchi   +2 more
exaly  

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts

New England Journal of Medicine, 2023
Nicola A Hanania, Stephanie A Christenson, Alberto A Papi   +2 more
exaly  

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Lancet, The, 2017
Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham   +2 more
exaly  

Dupilumab’s duplicity

Journal of the American Academy of Dermatology
openaire   +2 more sources

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Lancet, The, 2019
Claus Bachert, Ludger Klimek, Martin Desrosiers   +2 more
exaly  

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Lancet, The, 2016
Thomas Bieber, Andrew Blauvelt, Margitta Worm   +2 more
exaly